)
Drug major Ranbaxy Laboratories today posted a consolidated net loss of Rs 454.16 crore for the third quarter ended September 30, 2013.
The company had posted net profit of Rs 754.17 crore during the same period of previous year.
Net sales of the company, however, rose to Rs 2,750.17 crore during the third quarter, as compared to Rs 2,668.52 crore in the same period of previous year, Ranbaxy Laboratories said in a filing to the BSE.
Ranbaxy scrip close at Rs 385.65 on the BSE, down 0.82%.
